scholarly journals Predicting cause of death from free-text health summaries: development of an interpretable machine learning tool

Author(s):  
Chris McWilliams ◽  
Eleanor Walsh ◽  
Avon Huxor ◽  
Emma L Turner ◽  
Raul Santos-Rodriguez

Purpose: Accurately assigning cause of death is vital to understanding health outcomes in the population and improving health care provision. Cancer-specific cause of death is a key outcome in clinical trials, but assignment of cause of death from death certification is prone to misattribution, therefore can have an impact on cancer-specific trial mortality outcome measures. Methods: We developed an interpretable machine learning classifier to predict prostate cancer death from free-text summaries of medical history for prostate cancer patients (CAP). We developed visualisations to highlight the predictive elements of the free-text summaries. These were used by the project analysts to gain an insight of how the predictions were made. Results: Compared to independent human expert assignment, the classifier showed >90% accuracy in predicting prostate cancer death in test subset of the CAP dataset. Informal feedback suggested that these visualisations would require adaptation to be useful to clinical experts when assessing the appropriateness of these ML predictions in a clinical setting. Notably, key features used by the classifier to predict prostate cancer death and emphasised in the visualisations, were considered to be clinically important signs of progressing prostate cancer based on prior knowledge of the dataset. Conclusion: The results suggest that our interpretability approach improve analyst confidence in the tool, and reveal how the approach could be developed to produce a decision-support tool that would be useful to health care reviewers. As such, we have published the code on GitHub to allow others to apply our methodology to their data (https://zenodo.org/badge/latestdoi/294910364).

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Matthew Cooperberg ◽  
Anamaria Crisan ◽  
Anirban Mitra ◽  
Mercedeh Ghadessi ◽  
Christine Buerki ◽  
...  

2018 ◽  
Vol 27 (01) ◽  
pp. 127-128

Chen JH, Alagappan M, Goldstein MK, Asch SM, Altman RB. Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets. Int J Med Inform 2017 Jun;102:71-9 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28495350/ Ebadi A, Tighe PJ, Zhang L, Rashidi P. DisTeam: A decision support tool for surgical team selection. Artif Intell Med 2017 Feb;76:16-26 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28363285/ Fung KW, Kapusnik-Uner J, Cunningham J, Higby-Baker S, Bodenreider O. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support. J Am Med Inform Assoc 2017 Jul 1;24(4):806-12 https://academic.oup.com/jamia/article-lookup/doi/10.1093/jamia/ocx010 Mikalsen KØ, Soguero-Ruiz C, Jensen K, Hindberg K, Gran M, Revhaug A, Lindsetmo RO, Skrøvseth SO, Godtliebsen F, Jenssen R. Using anchors from free text in electronic health records to diagnose postoperative delirium. Comput Methods Programs Biomed 2017 Dec;152:105-14 https://linkinghub.elsevier.com/retrieve/pii/S0169-2607(17)31154-9


Author(s):  
A. I. Peltomaa ◽  
P. Raittinen ◽  
K. Talala ◽  
K. Taari ◽  
T. L. J. Tammela ◽  
...  

Abstract Purpose Statins’ cholesterol-lowering efficacy is well-known. Recent epidemiological studies have found that inhibition of cholesterol synthesis may have beneficial effects on prostate cancer (PCa) patients, especially patients treated with androgen deprivation therapy (ADT). We evaluated statins’ effect on prostate cancer prognosis among patients treated with ADT. Materials and methods Our study population consisted of 8253 PCa patients detected among the study population of the Finnish randomized study of screening for prostate cancer. These were limited to 4428 men who initiated ADT during the follow-up. Cox proportional regression model adjusted for tumor clinical characteristics and comorbidities was used to estimate hazard ratios for risk of PSA relapse after ADT initiation and prostate cancer death. Results During the median follow-up of 6.3 years after the ADT initiation, there were 834 PCa deaths and 1565 PSA relapses in a study cohort. Statin use after ADT was associated with a decreased risk of PSA relapse (HR 0.73, 95% CI 0.65–0.82) and prostate cancer death (HR 0.82; 95% CI 0.69–0.96). In contrast, statin use defined with a one-year lag (HR 0.89, 95% CI 0.76–1.04), statin use before ADT initiation (HR 1.12, 95% CI 0.96–1.31), and use in the first year on ADT (HR 1.02, 95% CI 0.85–1.24) were not associated with prostate cancer death, without dose dependency. Conclusion Statin use after initiation of ADT, but not before, was associated with improved prostate cancer prognosis.


Symmetry ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 330 ◽  
Author(s):  
Muhammad Aslam ◽  
Mohammed Albassam

This paper presents an epidemiological study on the dietary fat that causes prostate cancer in an uncertainty environment. To study this relationship under the indeterminate environment, data from 30 countries are selected for the prostate cancer death rate and dietary fat level in the food. The neutrosophic correlation and regression line are fitted on the data. We note from the neutrosophic analysis that the prostate cancer death rate increases as the dietary fat level in the people increases. The neutrosophic regression coefficient also confirms this claim. From this study, we conclude that neutrosophic regression is a more effective model under uncertainty than the regression model under classical statistics. We also found a statistical correlation between dietary fat and prostate cancer risk.


2019 ◽  
Vol 32 (9) ◽  
pp. 1303-1309 ◽  
Author(s):  
Solène-Florence Kammerer-Jacquet ◽  
Amar Ahmad ◽  
Henrik Møller ◽  
Holly Sandu ◽  
Peter Scardino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document